Specialized catheter that delivers pulsed electric fields to the duodenum
Total Trials
8
As Lead Sponsor
5
As Collaborator
3
Total Enrollment
1,053
NCT01223469
TOCCATA - Touch+™ for Catheter Ablation
Phase: N/A
Role: Collaborator
Start: Sep 30, 2008
Completion: Feb 28, 2010
NCT02131337
TactiCath® Prospective Effectiveness Pilot Study
Start: Dec 31, 2010
Completion: Oct 31, 2011
NCT04725890
Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes
Role: Lead Sponsor
Start: Feb 3, 2021
Completion: Dec 22, 2024
NCT05014204
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
Start: Oct 29, 2021
Completion: Mar 31, 2025
NCT05984238
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)
Start: Aug 3, 2023
Completion: Oct 31, 2025
NCT06267391
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Start: May 1, 2024
Completion: Oct 1, 2026
NCT07197775
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Start: Oct 31, 2025
Completion: May 31, 2032
NCT07197788
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Completion: Oct 31, 2027
Loading map...